Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Predictors of visual and anatomical outcomes for neovascular age-related macular degeneration treated with bevacizumab.

Ma C, Bai L, Lei C, Wu C, Shi Q, Hu F, Hao Z, Ma LE.

Biomed Rep. 2015 Jul;3(4):503-508. Epub 2015 Apr 16.

PMID:
26171156
2.

PEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseases.

He X, Cheng R, Benyajati S, Ma JX.

Clin Sci (Lond). 2015 Jun;128(11):805-23. doi: 10.1042/CS20130463. Review.

PMID:
25881671
3.

Expression of pigment epithelium-derived factor and thrombospondin-1 regulate proliferation and migration of retinal pigment epithelial cells.

Farnoodian M, Kinter JB, Yadranji Aghdam S, Zaitoun I, Sorenson CM, Sheibani N.

Physiol Rep. 2015 Jan 19;3(1). pii: e12266. doi: 10.14814/phy2.12266. Print 2015 Jan 1.

PMID:
25602019
4.

Pigment epithelium-derived factor inhibits retinal microvascular dysfunction induced by 12/15-lipoxygenase-derived eicosanoids.

Ibrahim AS, Tawfik AM, Hussein KA, Elshafey S, Markand S, Rizk N, Duh EJ, Smith SB, Al-Shabrawey M.

Biochim Biophys Acta. 2015 Mar;1851(3):290-8. doi: 10.1016/j.bbalip.2014.12.017. Epub 2015 Jan 3.

PMID:
25562624
5.

Endostar, a modified recombinant human endostatin, suppresses angiogenesis through inhibition of Wnt/β-catenin signaling pathway.

Xu X, Mao W, Chen Q, Zhuang Q, Wang L, Dai J, Wang H, Huang Z.

PLoS One. 2014 Sep 18;9(9):e107463. doi: 10.1371/journal.pone.0107463. eCollection 2014.

PMID:
25232946
6.

Growth factors/chemokines in diabetic vitreous and aqueous alter the function of bone marrow-derived progenitor (CD34⁺) cells in humans.

Balaiya S, Grant MB, Priluck J, Chalam KV.

Am J Physiol Endocrinol Metab. 2014 Oct 15;307(8):E695-702. doi: 10.1152/ajpendo.00253.2014. Epub 2014 Aug 26.

PMID:
25159325
7.

Aqueous interleukin-6 levels are superior to vascular endothelial growth factor in predicting therapeutic response to bevacizumab in age-related macular degeneration.

Chalam KV, Grover S, Sambhav K, Balaiya S, Murthy RK.

J Ophthalmol. 2014;2014:502174. doi: 10.1155/2014/502174. Epub 2014 Jul 10.

PMID:
25110587
8.

Omega-3 supplementation combined with anti-vascular endothelial growth factor lowers vitreal levels of vascular endothelial growth factor in wet age-related macular degeneration.

Rezende FA, Lapalme E, Qian CX, Smith LE, SanGiovanni JP, Sapieha P.

Am J Ophthalmol. 2014 Nov;158(5):1071-78. doi: 10.1016/j.ajo.2014.07.036. Epub 2014 Aug 1.

PMID:
25089351
9.

Thrombospondin-1 Deficiency Exacerbates the Pathogenesis of Diabetic Retinopathy.

Sorenson CM, Wang S, Gendron R, Paradis H, Sheibani N.

J Diabetes Metab. 2013 May 25;Suppl 12. doi: 10.4172/2155-6156.S12-005.

PMID:
24224119
10.

Osteopontin and other regulators of angiogenesis and fibrogenesis in the vitreous from patients with proliferative vitreoretinal disorders.

Abu El-Asrar AM, Imtiaz Nawaz M, Kangave D, Siddiquei MM, Geboes K.

Mediators Inflamm. 2012;2012:493043. doi: 10.1155/2012/493043. Epub 2012 Sep 29.

PMID:
23055574
11.

Characterisation of the vitreous proteome in proliferative diabetic retinopathy.

Wang H, Feng L, Hu JW, Xie CL, Wang F.

Proteome Sci. 2012 Mar 5;10(1):15. doi: 10.1186/1477-5956-10-15.

PMID:
22390717
12.

Alzheimer's disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful aging.

Maarouf CL, Daugs ID, Kokjohn TA, Walker DG, Hunter JM, Kruchowsky JC, Woltjer R, Kaye J, Castaño EM, Sabbagh MN, Beach TG, Roher AE.

PLoS One. 2011;6(11):e27291. doi: 10.1371/journal.pone.0027291. Epub 2011 Nov 7.

PMID:
22087282
13.

Role of vascular endothelial growth factor in the breakdown of the blood-aqueous barrier after retinal laser photocoagulation in pigmented rabbits.

Chen MS, Chang CC, Lin CP, Wang PC, Lin LR, Hou PK, Ho TC.

J Ocul Pharmacol Ther. 2012 Feb;28(1):83-8. doi: 10.1089/jop.2011.0030. Epub 2011 Oct 19.

PMID:
22011077
14.

Bevacizumab neutralizes the protective effect of vascular endothelial growth factor on retinal ganglion cells.

Brar VS, Sharma RK, Murthy RK, Chalam KV.

Mol Vis. 2010 Sep 12;16:1848-53.

PMID:
21031022
15.

Pigment epithelium-derived factor receptor (PEDF-R): a plasma membrane-linked phospholipase with PEDF binding affinity.

Subramanian P, Notario PM, Becerra SP.

Adv Exp Med Biol. 2010;664:29-37. doi: 10.1007/978-1-4419-1399-9_4.

PMID:
20237999
16.

Delivery of celecoxib for treating diseases of the eye: influence of pigment and diabetes.

Amrite A, Pugazhenthi V, Cheruvu N, Kompella U.

Expert Opin Drug Deliv. 2010 May;7(5):631-45. doi: 10.1517/17425241003663236. Review.

PMID:
20205602
17.

Proteome Profiling of Vitreoretinal Diseases by Cluster Analysis.

Shitama T, Hayashi H, Noge S, Uchio E, Oshima K, Haniu H, Takemori N, Komori N, Matsumoto H.

Proteomics Clin Appl. 2008 Sep;2(9):1265-1280.

PMID:
19081814
18.

Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors.

Saint-Geniez M, Maharaj AS, Walshe TE, Tucker BA, Sekiyama E, Kurihara T, Darland DC, Young MJ, D'Amore PA.

PLoS One. 2008;3(11):e3554. doi: 10.1371/journal.pone.0003554. Epub 2008 Nov 3.

PMID:
18978936
19.

Inhibition of nuclear translocation of apoptosis-inducing factor is an essential mechanism of the neuroprotective activity of pigment epithelium-derived factor in a rat model of retinal degeneration.

Murakami Y, Ikeda Y, Yonemitsu Y, Onimaru M, Nakagawa K, Kohno R, Miyazaki M, Hisatomi T, Nakamura M, Yabe T, Hasegawa M, Ishibashi T, Sueishi K.

Am J Pathol. 2008 Nov;173(5):1326-38. doi: 10.2353/ajpath.2008.080466. Epub 2008 Oct 9.

PMID:
18845835
20.

Whole genome assessment of the retinal response to diabetes reveals a progressive neurovascular inflammatory response.

Brucklacher RM, Patel KM, VanGuilder HD, Bixler GV, Barber AJ, Antonetti DA, Lin CM, LaNoue KF, Gardner TW, Bronson SK, Freeman WM.

BMC Med Genomics. 2008 Jun 13;1:26. doi: 10.1186/1755-8794-1-26.

PMID:
18554398
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk